GERIATRIC ONCOLOGY CONSORTIUM

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
First Posted Date
2005-09-22
Last Posted Date
2007-11-19
Lead Sponsor
Geriatric Oncology Consortium
Target Recruit Count
17
Registration Number
NCT00215709

Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel

Phase 2
Terminated
Conditions
Breast Cancer
Lung Cancer
First Posted Date
2005-09-22
Last Posted Date
2007-11-16
Lead Sponsor
Geriatric Oncology Consortium
Target Recruit Count
40
Registration Number
NCT00215748

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Phase 2
Terminated
Conditions
Colorectal Cancer
Neoplasm Metastasis
First Posted Date
2005-07-15
Last Posted Date
2007-11-16
Lead Sponsor
Geriatric Oncology Consortium
Target Recruit Count
40
Registration Number
NCT00120172

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Phase 2
Terminated
Conditions
Non-Hodgkin's Lymphoma
First Posted Date
2005-07-15
Last Posted Date
2007-11-16
Lead Sponsor
Geriatric Oncology Consortium
Target Recruit Count
50
Registration Number
NCT00120198
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy